This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The Bidar API manufacturing facility of Sai Life Sciences has been on a path of significant expansion with its production capacity growing from 200KL in 2017 to 450KL
Subscribe To Our Newsletter & Stay Updated
